Fuji Pharma Co., Ltd. (TYO:4554)
Japan
· Delayed Price · Currency is JPY 1,325.00
-10.00 (-0.75%)
Jul 16, 2025, 3:30 PM JST
Fuji Pharma Revenue
Fuji Pharma had revenue of 11.10B JPY in the quarter ending March 31, 2025, with 4.26% growth. This brings the company's revenue in the last twelve months to 48.85B, up 13.46% year-over-year. In the fiscal year ending September 30, 2024, Fuji Pharma had annual revenue of 46.14B with 12.84% growth.
Revenue (ttm)
48.85B
Revenue Growth
+13.46%
P/S Ratio
0.67
Revenue / Employee
29.46M
Employees
1,658
Market Cap
32.61B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 46.14B | 5.25B | 12.84% |
| Sep 30, 2023 | 40.89B | 5.46B | 15.42% |
| Sep 30, 2022 | 35.43B | 1.44B | 4.22% |
| Sep 30, 2021 | 33.99B | 197.00M | 0.58% |
| Sep 30, 2020 | 33.79B | -2.49B | -6.85% |
| Sep 30, 2019 | Pro | Pro | Pro |
| Sep 30, 2018 | Pro | Pro | Pro |
| Sep 30, 2017 | Pro | Pro | Pro |
| Sep 30, 2016 | Pro | Pro | Pro |
| Sep 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Takeda Pharmaceutical Company | 4,581.55B |
| Daiichi Sankyo Company | 1,886.26B |
| HOYA Corporation | 866.03B |
| Terumo | 1,036.17B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Shionogi & | 438.27B |
Fuji Pharma News
- 19 days ago - Alvotech's Lenders Lower Interest on Senior Secured Term Loan Facility - Benzinga
- 4 months ago - Olic anticipates buoyant demand for contraceptives - Bangkok Post